Relationship Between β-Cell Mass and Fasting Blood Glucose Concentration in Humans

Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin

(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011

β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes

Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011

U.K. Prospective Diabetes Study 16: Overview of 6 Years' Therapy of Type II Diabetes: A Progressive Disease

U.K. Prospective Diabetes Study Group (1995) · Diabetes · doi:10.2337/diab.44.11.1249 · Cited by 1,923

Preservation of Pancreatic β-Cell Function and Prevention of Type 2 Diabetes by Pharmacological Treatment of Insulin Resistance in High-Risk Hispanic Women

Buchanan, T. A., Xiang, A. H., Peters, R. K., Kjos, S. L., Marroquin, A., Goico, J., Ochoa, C., Tan, S., Berkowitz, K., Hodis, H. N., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2796 · Cited by 1,339

U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group

(1995) · Diabetes · doi:10.2337/diabetes.44.11.1249 · Cited by 796

Selective β-Cell Loss and α-Cell Expansion in Patients with Type 2 Diabetes Mellitus in Korea

Yoon, K., Ko, S., Cho, J., Lee, J. M., Ahn, Y., Song, K. H., Yoo, S. J., Kang, M. I., Cha, B. Y., Lee, K. W., et al. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020735 · Cited by 651

Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited.

Klöppel, G., Löhr, M., Habich, K., Oberholzer, M., & Heitz, P. (1985) · Survey and Synthesis of Pathology Research · doi:10.1159/000156969 · Cited by 645

Decreased beta-cell mass in diabetes: significance, mechanisms and therapeutic implications

Donath, M. Y., & Halban, P. A. (2004) · Diabetologia · doi:10.1007/s00125-004-1336-4 · Cited by 430

Superoxide-mediated activation of uncoupling protein 2 causes pancreatic β cell dysfunction

Krauss, S., Zhang, C., Scorrano, L., Dalgaard, L. T., St‐Pierre, J., Grey, S. T., & Lowell, B. B. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19774 · Cited by 405

Superoxide-mediated activation of uncoupling protein 2 causes pancreatic β cell dysfunction

Krauss, S., Zhang, C.-Y., Scorrano, L., Dalgaard, L. T., St-Pierre, J., Grey, S. T., & Lowell, B. B. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319774 · Cited by 401

β-Cell Replication Is the Primary Mechanism Subserving the Postnatal Expansion of β-Cell Mass in Humans

Meier, J. J., Butler, A. E., Saisho, Y., Monchamp, T., Galasso, R., Bhushan, A., Rizza, R. A., & Butler, P. C. (2008) · Diabetes · doi:10.2337/db07-1369 · Cited by 683

Islet Amyloid in Type 2 Diabetes, and the Toxic Oligomer Hypothesis

Haataja, L., Gurlo, T., Huang, C. J., & Butler, P. C. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0037 · Cited by 624

Defining and Characterizing the Progression of Type 2 Diabetes

Fonseca, V. A. (2009) · Diabetes Care · doi:10.2337/dc09-s301 · Cited by 573

Expansion of β-cell mass in response to pregnancy

Rieck, S., & Kaestner, K. H. (2010) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2009.11.001 · Cited by 358

The replication of β cells in normal physiology, in disease and for therapy

Butler, P. C., Meier, J. J., Butler, A. E., & Bhushan, A. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0647 · Cited by 268

β-cell dysfunction: Its critical role in prevention and management of type 2 diabetes

Saisho, Y. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i1.109 · Cited by 263

Relationship between β‐cell mass and diabetes onset

Matveyenko, A. V., & Butler, P. C. (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00939.x · Cited by 249

The long lifespan and low turnover of human islet beta cells estimated by mathematical modelling of lipofuscin accumulation

Cnop, M., Hughes, S. J., Igoillo‐Esteve, M., Hoppa, M. B., Sayyed, F., van de Laar, L., Gunter, J. H., de Koning, E. J. P., Walls, G. V., Gray, D. W. G., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1562-x · Cited by 243

Diabetes mellitus—advances and challenges in human β-cell proliferation

Wang, P., Fiaschi‐Taesch, N., Vasavada, R. C., Scott, D. K., García-Ocaña, A., & Stewart, A. F. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.9 · Cited by 210

Combination Therapy With Glucagon-Like Peptide-1 and Gastrin Restores Normoglycemia in Diabetic NOD Mice

Suarez‐Pinzon, W. L., Power, R. F., Yan, Y., Wasserfall, C. H., Atkinson, M. A., & Rabinovitch, A. (2008) · Diabetes · doi:10.2337/db08-0688 · Cited by 184

Lean diabetes mellitus: An emerging entity in the era of obesity

George, A. M., Jacob, A. G., & Fogelfeld, L. (2015) · World Journal of Diabetes · doi:10.4239/wjd.v6.i4.613 · Cited by 177

Partial pancreatectomy in adult humans does not provoke β-cell regeneration

Menge, B. A., Tannapfel, A., Belyaev, O., Drescher, R., Müller, C., Uhl, W., Schmidt, W. E., & Meier, J. J. (2008) · Diabetes · doi:10.2337/db07-1294 · Cited by 173

Functional Assessment of Pancreatic β-Cell Area in Humans

Meier, J. J., Menge, B. A., Breuer, T. G. K., Müller, C., Tannapfel, A., Uhl, W. H., Schmidt, W. E., & Schrader, H. (2009) · Diabetes · doi:10.2337/db08-1611 · Cited by 164

Minireview: Meeting the Demand for Insulin: Molecular Mechanisms of Adaptive Postnatal ß-Cell Mass Expansion

Sachdeva, M. M., & Stoffers, D. A. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0400 · Cited by 162

β-Cell Mass Dynamics and Islet Cell Plasticity in Human Type 2 Diabetes

Hanley, S. C., Austin, E. B., Assouline-Thomas, B., Kapeluto, J., Blaichman, J. I., Moosavi, M., Petropavlovskaia, M., & Rosenberg, L. C. (2010) · Endocrinology · doi:10.1210/en.2009-1277 · Cited by 160

Beta cell mass in diabetes: a realistic therapeutic target?

Meier, J. J. (2008) · Diabetologia · doi:10.1007/s00125-008-0936-9 · Cited by 155

Dysfunction of Persisting β Cells Is a Key Feature of Early Type 2 Diabetes Pathogenesis

Cohrs, C. M., Panzer, J. K., Drotar, D. M., Enos, S. J., Kipke, N., Chen, C., Bozsak, R., Schöniger, E., Ehehalt, F., Distler, M., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.03.033 · Cited by 159

β-Cell Deficit Due to Increased Apoptosis in the Human Islet Amyloid Polypeptide Transgenic (HIP) Rat Recapitulates the Metabolic Defects Present in Type 2 Diabetes

Matveyenko, A. V., & Butler, P. C. (2006) · Diabetes · doi:10.2337/db05-1672 · Cited by 144

Pancreatic diabetes manifests when beta cell area declines by approximately 65% in humans

Meier, J. J., Breuer, T. G. K., Bonadonna, R. C., Tannapfel, A., Uhl, W. H., Schmidt, W. E., Schrader, H., & Menge, B. (2012) · Diabetologia · doi:10.1007/s00125-012-2466-8 · Cited by 148

Non-invasive quantification of the beta cell mass by SPECT with 111In-labelled exendin

Brom, M., der Weg, W. W.-V., Joosten, L., Frielink, C., Bouckenooghe, T., Rijken, P. F. J. W., Andralojc, K. M., Göke, B., de Jong, M., Eizirik, D. L., et al. (2014) · Diabetologia · doi:10.1007/s00125-014-3166-3 · Cited by 139

Adenosine kinase inhibition selectively promotes rodent and porcine islet β-cell replication

Annes, J. P., Kenty, J. H.-R., Lam, K., Carolan, P. J., Utz, K., Hollister‐Lock, J., Arvanites, A. C., Rubin, L. L., Weir, G. C., & Melton, D. A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201149109 · Cited by 139

Modestly increased beta cell apoptosis but no increased beta cell replication in recent-onset type 1 diabetic patients who died of diabetic ketoacidosis

Butler, A. E., Galasso, R., Meier, J. J., Basu, R., Rizza, R. A., & Butler, P. C. (2007) · Diabetologia · doi:10.1007/s00125-007-0794-x · Cited by 137

Pancreatic β-Cell Proliferation in Obesity

Linnemann, A. K., Baan, M., & Davis, D. B. (2014) · Advances in Nutrition · doi:10.3945/an.113.005488 · Cited by 132

β-Cell Failure in Type 2 Diabetes: A Case of Asking Too Much of Too Few?

Costes, S., Langen, R., Gurlo, T., Matveyenko, A. V., & Butler, P. C. (2013) · Diabetes · doi:10.2337/db12-1326 · Cited by 129

Mathematical models of diabetes progression

Gaetano, A. D., Hardy, T. A., Beck, B., Abu-Raddad, E., Palumbo, P. J., Bue‐Valleskey, J. M., & Pørksen, N. K. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90444.2008 · Cited by 120

Visualizing pancreatic β-cell mass with [11C]DTBZ

Simpson, N. R., Souza, F., Witkowski, P., Maffei, A., Raffo, A. J., Herron, A. J., Kilbourn, M. R., Jurewicz, A., Herold, K. C., Liu, E., et al. (2006) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2006.07.002 · Cited by 117

The effects of glucagon‐like peptide‐1 on the beta cell

Vilsbøll, T. (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01073.x · Cited by 116

Impaired islet turnover in human donor pancreata with aging

Reers, C., Erbel, S., Esposito, I., Schmied, B., Büchler, M. W., Nawroth, P. P., & Ritzel, R. A. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0596 · Cited by 113

β-Cell Deficit in Obese Type 2 Diabetes, a Minor Role of β-Cell Dedifferentiation and Degranulation

Butler, A. E., Dhawan, S., Hoang, J. D., Cory, M., Zeng, K., Fritsch, H., Meier, J. J., Rizza, R. A., & Butler, P. C. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3566 · Cited by 113

Targeting β-Cell Mass in Type 2 Diabetes: Promise and Limitations of New Drugs Based on Incretins

Salehi, M., Aulinger, B. A., & D’Alessio, D. A. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0031 · Cited by 107

Reduced Pancreatic Volume and β-Cell Area in Patients With Chronic Pancreatitis

Schrader, H., Menge, B. A., Schneider, S., Belyaev, O., Tannapfel, A., Uhl, W. H., Schmidt, W. E., & Meier, J. J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.10.083 · Cited by 109

Pancreatic Volumetric Assessment as a Predictor of New-Onset Diabetes Following Distal Pancreatectomy

Shirakawa, S., Matsumoto, I., Toyama, H., Shinzeki, M., Ajiki, T., Fukumoto, T., & Ku, Y. (2012) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-012-2039-7 · Cited by 102

Longevity of human islet α ‐ and β ‐cells

Cnop, M., Igoillo‐Esteve, M., Hughes, S. J., Walker, J. N., Cnop, I., & Clark, A. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01443.x · Cited by 100

FoxM1 Is Up-Regulated by Obesity and Stimulates β-Cell Proliferation

Davis, D. B., Lavine, J. A., Suhonen, J. I., Krautkramer, K. A., Rabaglia, M. E., Sperger, J. M., Fernandez, L. A., Yandell, B. S., Keller, M. P., Wang, I., et al. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0082 · Cited by 90

Cannabinoids Induce Pancreatic β-Cell Death by Directly Inhibiting Insulin Receptor Activation

Kim, W., Lao, Q., Shin, Y., Carlson, O. D., Lee, E. K., Gorospe, M., Kulkarni, R., & Egan, J. M. (2012) · Science Signaling · doi:10.1126/scisignal.2002519 · Cited by 90

Non-obese patients with type 2 diabetes and prediabetic subjects: distinct phenotypes requiring special diabetes treatment and (or) prevention?

Vaag, A., & Lund, S. S. (2007) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h07-100 · Cited by 89

Metabolic consequences of a 50% partial pancreatectomy in humans

Menge, B., Schrader, H., Breuer, T. G. K., Dabrowski, Y., Uhl, W. H., Schmidt, W. E., & Meier, J. J. (2008) · Diabetologia · doi:10.1007/s00125-008-1219-1 · Cited by 86

Relationship between pancreatic vesicular monoamine transporter 2 (VMAT2) and insulin expression in human pancreas

Saisho, Y., Harris, P. E., Butler, A. E., Galasso, R., Gurlo, T., Rizza, R. A., & Butler, P. C. (2008) · Journal of Molecular Histology · doi:10.1007/s10735-008-9195-9 · Cited by 85

Glucolipotoxicity and beta cells in type 2 diabetes mellitus: Target for durable therapy?

van Raalte, D. H., & Diamant, M. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(11)70012-2 · Cited by 87

Glucolipotoxicity in Pancreatic β-Cells

Kim, J.-W., & Yoon, K.-H. (2011) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2011.35.5.444 · Cited by 82

What is type 2 diabetes?

Smushkin, G., & Vella, A. V. (2010) · Medicine · doi:10.1016/j.mpmed.2010.08.008 · Cited by 82

Free Fatty Acids Block Glucose-Induced β-Cell Proliferation in Mice by Inducing Cell Cycle Inhibitors p16 and p18

Pascoe, J. L., Hollern, D. A., Stamateris, R. E., Abbasi, M., Romano, L. C., Zou, B., O'Donnell, C. P., Garcı́a-Ocaña, A., & Alonso, L. C. (2012) · Diabetes · doi:10.2337/db11-0991 · Cited by 76

Cholecystokinin Is Up-Regulated in Obese Mouse Islets and Expands β-Cell Mass by Increasing β-Cell Survival

Lavine, J. A., Raess, P. W., Stapleton, D. S., Rabaglia, M. E., Suhonen, J. I., Schueler, K. L., Koltes, J. E., Dawson, J., Yandell, B. S., Samuelson, L. C., et al. (2010) · Endocrinology · doi:10.1210/en.2010-0233 · Cited by 71

CC-401 Promotes β-Cell Replication via Pleiotropic Consequences of DYRK1A/B Inhibition

Abdolazimi, Y., Zhao, Z., Lee, S., Xu, H., Allegretti, P. A., Horton, T. M., Yeh, B. T., Moeller, H. P., Nichols, R. J., McCutcheon, D., et al. (2018) · Endocrinology · doi:10.1210/en.2018-00083 · Cited by 68

A dominant role for glucose in β cell compensation of insulin resistance

Weir, G. C., & Bonner‐Weir, S. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30862 · Cited by 70

β‐cell mass in people with type 2 diabetes

Cho, J., Kim, J., Shin, J., Shin, J., & Yoon, K. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00072.x · Cited by 69

ACE2 deficiency reduces β-cell mass and impairs β-cell proliferation in obese C57BL/6 mice

Shoemaker, R., Yiannikouris, F. B., Thatcher, S. E., & Cassis, L. A. (2015) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00054.2015 · Cited by 70

Posttransplant Diabetes Mellitus After Pancreas Transplantation

Dean, P. G., Kudva, Y. C., Larson, T. S., Kremers, W. K., & Stegall, M. D. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.02018.x · Cited by 68

Cyclin D2 Is Essential for the Compensatory β-Cell Hyperplastic Response to Insulin Resistance in Rodents

Georgia, S. K., Hinault, C., Kawamori, D., Hu, J., Meyer, J., Kanji, M., Bhushan, A., & Kulkarni, R. N. (2010) · Diabetes · doi:10.2337/db09-0838 · Cited by 68

Combination Therapy with Glucagon-Like Peptide-1 and Gastrin Induces β-Cell Neogenesis from Pancreatic Duct Cells in Human Islets Transplanted in Immunodeficient Diabetic Mice

Suarez‐Pinzon, W. L., Lakey, J. R. T., & Rabinovitch, A. (2008) · Cell Transplantation · doi:10.3727/096368908786092775 · Cited by 65

Risk of Glucose Intolerance and Diabetes in Hemipancreatectomized Donors Selected for Normal Preoperative Glucose Metabolism

Kumar, A. F., Gruessner, R. W. G., & Seaquist, E. R. (2008) · Diabetes Care · doi:10.2337/dc07-2453 · Cited by 62

Targeting pancreatic β cells for diabetes treatment

Jain, C., Ansarullah, M., Bilekova, S., & Lickert, H. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00618-5 · Cited by 69

Gastrointestinal hormones and the regulation of β‐cell mass

Lavine, J. A., & Attie, A. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05802.x · Cited by 61

Goals of Treatment for Type 2 Diabetes

Marchetti, P., Lupi, R., Guerra, S. D., Bugliani, M., D’Aleo, V., Occhipinti, M., Boggi, U., Marselli, L., & Masini, M. (2009) · Diabetes Care · doi:10.2337/dc09-s306 · Cited by 62

Enhanced beta cell function and anti-inflammatory effect after chronic treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin in an advanced-aged diet-induced obesity mouse model

Omar, B. A., Vikman, J., Winzell, M. S., Voss, U., Ekblad, E., Foley, J. E., & Åhrén, B. (2013) · Diabetologia · doi:10.1007/s00125-013-2927-8 · Cited by 61

Differential effect of sulfonylureas on production of reactive oxygen species and apoptosis in cultured pancreatic β-cell line, MIN6

Sawada, F., Inoguchi, T., Tsubouchi, H., Sasaki, S., Fujii, M., Maeda, Y., Morinaga, H., Nomura, M., Kobayashi, K., & Takayanagi, R. (2008) · Metabolism · doi:10.1016/j.metabol.2008.01.038 · Cited by 63

Interventions to Preserve Beta-Cell Function in the Management and Prevention of Type 2 Diabetes

Page, K. A., & Reisman, T. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0363-2 · Cited by 62

Tissue-specific regulation and expression of heat shock proteins in type 2 diabetic monkeys

Kavanagh, K., Zhang, L., & Wagner, J. D. (2008) · Cell Stress and Chaperones · doi:10.1007/s12192-008-0084-7 · Cited by 59

Pathways governing development of stem cell‐derived pancreatic β cells: lessons from embryogenesis

Al‐Khawaga, S., Memon, B., Butler, A. E., Taheri, S., Abou‐Samra, A., & Abdelalim, E. M. (2017) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12349 · Cited by 59

MST1: a promising therapeutic target to restore functional beta cell mass in diabetes

Ardestani, A. D., & Maedler, K. (2016) · Diabetologia · doi:10.1007/s00125-016-3892-9 · Cited by 56

Δ40 Isoform of p53 Controls β-Cell Proliferation and Glucose Homeostasis in Mice

Hinault, C., Kawamori, D., Liew, C. W., Maier, B., Hu, J., Keller, S. R., Mirmira, R. G., Scrable, H. J., & Kulkarni, R. (2011) · Diabetes · doi:10.2337/db09-1379 · Cited by 57

Human Beta Cell Regenerative Drug Therapy for Diabetes: Past Achievements and Future Challenges

Wang, P., Karaköse, E., Choleva, L., Kumar, K., DeVita, R. J., García-Ocaña, A., & Stewart, A. F. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.671946 · Cited by 54

Effects of Obesity and Diabetes on α- and β-Cell Mass in Surgically Resected Human Pancreas

Inaishi, J., Saisho, Y., Sato, S., Kou, K., Murakami, R., Watanabe, Y., Kitago, M., Kitagawa, Y., Yamada, T., & Itoh, H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1374 · Cited by 54

Protective Effects of Dipeptidyl Peptidase-4 (DPP-4) Inhibitor against Increased β Cell Apoptosis Induced by Dietary Sucrose and Linoleic Acid in Mice with Diabetes

Shirakawa, J., Amo, K., Ohminami, H., Orime, K., Togashi, Y., Ito, Y., Tajima, K., Koganei, M., Sasaki, H., Takeda, E., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.217216 · Cited by 53

(Re)generating Human Beta Cells: Status, Pitfalls, and Perspectives

Baeyens, L., Lemper, M., Staels, W., Groef, S. D., Leu, N. D., Heremans, Y., German, M. S., & Heimberg, H. (2018) · Physiological Reviews · doi:10.1152/physrev.00034.2016 · Cited by 52

Insulin secretion and insulin-producing tumors

Guettier, J., & Görden, P. (2010) · Expert Review of Endocrinology & Metabolism · doi:10.1586/eem.09.83 · Cited by 49

Determinants of glucose control in patients with chronic pancreatitis

Schrader, H., Menge, B., Zeidler, C., Ritter, P. R., Tannapfel, A., Uhl, W. H., Schmidt, W. E., & Meier, J. J. (2010) · Diabetologia · doi:10.1007/s00125-010-1705-0 · Cited by 45

A concerted decline in insulin secretion and action occurs across the spectrum of fasting and postchallenge glucose concentrations

Sathananthan, A., Man, C. D., Zinsmeister, A. R., Camilleri, M., Rodeheffer, R. J., TOFFOLO, G. M., Cobelli, C., Rizza, R. A., & Vella, A. V. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04159.x · Cited by 44

Differential Development of Glucose Intolerance and Pancreatic Islet Adaptation in Multiple Diet Induced Obesity Models

Omar, B. A., Pacini, G., & Åhrén, B. (2012) · Nutrients · doi:10.3390/nu4101367 · Cited by 43

VMAT2 quantitation by PET as a biomarker for β‐cell mass in health and disease

Freeby, M., Goland, R., Ichise, M., Maffei, A., Leibel, R. L., & Harris, P. E. (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00943.x · Cited by 43

Beta cell imaging – a key tool in optimized diabetes prevention and treatment

Gotthardt, M., Eizirik, D. L., Cnop, M., & Brom, M. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.02.002 · Cited by 42

Ongoing β-Cell Turnover in Adult Nonhuman Primates Is Not Adaptively Increased in Streptozotocin-Induced Diabetes

Saisho, Y., Manesso, E., Butler, A. E., Galasso, R., Kavanagh, K., Flynn, M., Zhang, L., Clark, P. B., Gurlo, T., TOFFOLO, G. M., et al. (2011) · Diabetes · doi:10.2337/db09-1368 · Cited by 43

Development and assessment of the disposition index based on the oral glucose tolerance test in subjects with different glycaemic status

Santos, J. L., Yévenes, I., Cataldo, L. R., Morales, M., Galgani, J. E., Arancibia, C., Vega, J. L., Olmos, P. R., Flores, M., Valderas, J. P., et al. (2015) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-015-0458-0 · Cited by 42

A Model for Glucose, Insulin, and Beta‐Cell Dynamics in Subjects With Insulin Resistance and Patients With Type 2 Diabetes

Ribbing, J., Hamrén, B., Svensson, M. K. E., & Karlsson, M. O. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270009349711 · Cited by 39

Risk Factors Preceding Type 2 Diabetes and Cardiomyopathy

Singh, S., Dhingra, S., Ramdath, D. D., Vasdev, S., Gill, V. D., & Singal, P. K. (2010) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-010-9197-3 · Cited by 41

Chemiluminescence Imaging of Superoxide Anion Detects Beta-Cell Function and Mass

Bronsart, L. L., Stokes, C., & Contag, C. H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146601 · Cited by 38

Uncovering Pathways to Personalized Therapies in Type 1 Diabetes

Linsley, P. S., Greenbaum, C. J., & Nepom, G. T. (2021) · Diabetes · doi:10.2337/db20-1185 · Cited by 38

Islet Number Rather Than Islet Size Is a Major Determinant of β- and α-Cell Mass in Humans

Kou, K., Saisho, Y., Sato, S., Yamada, T., & Itoh, H. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3731 · Cited by 35

Use of insulin in type 2 diabetes: What we learned from recent clinical trials on the benefits of early insulin initiation

Hanefeld, M. (2014) · Diabetes & Metabolism · doi:10.1016/j.diabet.2014.08.006 · Cited by 43

The β-cell glucose toxicity hypothesis: Attractive but difficult to prove

Weir, G. C., Butler, P. C., & Bonner‐Weir, S. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154870 · Cited by 35

Early Treatment with Basal Insulin Glargine in People with Type 2 Diabetes: Lessons from ORIGIN and Other Cardiovascular Trials

Hanefeld, M., Monnier, L., Schnell, O., & Owens, D. R. (2016) · Diabetes Therapy · doi:10.1007/s13300-016-0153-3 · Cited by 36

Relationship between fractional pancreatic beta cell area and fasting plasma glucose concentration in monkeys

Saisho, Y., Butler, A. E., Manesso, E., Galasso, R., Zhang, L., Gurlo, T., TOFFOLO, G. M., Cobelli, C., Kavanagh, K., Wagner, J. D., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1552-z · Cited by 33

Increment of serum C-peptide measured by glucagon test closely correlates with human relative beta-cell area

Fujita, Y., Kozawa, J., Iwahashi, H., Yoneda, S., Uno, S., Yoshikawa, A., Okita, K., Eguchi, H., Nagano, H., Imagawa, A., et al. (2015) · Endocrine Journal · doi:10.1507/endocrj.ej14-0456 · Cited by 30

Repurposing cAMP-Modulating Medications to Promote β-Cell Replication

Zhao, Z., Low, Y., Armstrong, N., Kenty, J. H.-R., Sun, S. A., Arvanites, A. C., Hollister‐Lock, J., Shah, N. H., Weir, G. C., & Annes, J. P. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1120 · Cited by 30

Morphology of Pancreatic Islets: A Time Course of Pre-diabetes in Zucker Fatty Rats

Augstein, P., & Salzsieder, E. (2009) · Methods in molecular biology · doi:10.1007/978-1-59745-448-3_12 · Cited by 30

Pharmacotherapy of Diabetes: New Developments

Mogensen, C. E. (2007) · Springer eBooks · doi:10.1007/978-0-387-69737-6 · Cited by 30

A Novel TGR5 Activator WB403 Promotes GLP-1 Secretion and Preserves Pancreatic β-Cells in Type 2 Diabetic Mice

Zheng, C., Zhou, W., Wang, T., You, P., Zhao, Y., Yang, Y., Wang, X., Luo, J., Chen, Y., Liu, M., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0134051 · Cited by 30

Exendin-4 Protects Mitochondria from Reactive Oxygen Species Induced Apoptosis in Pancreatic Beta Cells

Li, Z., Zhou, Z., Huang, G., Hu, F., Xiang, Y., & He, L.-N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076172 · Cited by 32

Changing the Concept of Type 2 Diabetes: Beta Cell Workload Hypothesis Revisited

Saisho, Y. (2018) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530318666180821161825 · Cited by 29

Islet Regeneration: Endogenous and Exogenous Approaches

Docherty, F. M., & Sussel, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073306 · Cited by 28

Chemical Methods to Induce Beta-Cell Proliferation

Vetere, A., & Wagner, B. K. (2012) · International Journal of Endocrinology · doi:10.1155/2012/925143 · Cited by 27

Targeting GLP-1 receptors for repeated magnetic resonance imaging differentiates graded losses of pancreatic beta cells in mice

Vinet, L., Lamprianou, S., Babič, A., Lange, N., Thorel, F., Herrera, P. L., Montet, X., & Meda, P. (2014) · Diabetologia · doi:10.1007/s00125-014-3442-2 · Cited by 27

A novel fast-slow model of diabetes progression: Insights into mechanisms of response to the interventions in the Diabetes Prevention Program

Gaetano, A. D., & Hardy, T. A. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222833 · Cited by 29

Birth and Death of Human β-Cells in Pancreases from Cadaver Donors, Autopsies, Surgical Specimens, and Islets Transplanted into Mice

Caballero, F., Siniakowicz, K., Hollister‐Lock, J., Duran, L., Katsuta, H., Yamada, T., Lei, J., Deng, S., Westermark, G. T., Markmann, J. F., et al. (2013) · Cell Transplantation · doi:10.3727/096368912x659916 · Cited by 27

Therapeutic approaches based on beta-cell mass preservation and/or regeneration

Robert, A. R. (2009) · Frontiers in bioscience · doi:10.2741/3345 · Cited by 25

Insulin Resistance Compensation: Not Just a Matter of β-Cells?

Montanya, E. (2014) · Diabetes · doi:10.2337/db13-1843 · Cited by 27

Pancreatic islet reserve in type 1 diabetes

Flatt, A. J., Greenbaum, C. J., Shaw, J., & Rickels, M. R. (2021) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14572 · Cited by 27

Early Post-Renal Transplant Hyperglycemia

Iqbal, A., Zhou, K., Kashyap, S. R., & Lansang, M. C. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab697 · Cited by 26

Id3 upregulates BrdU incorporation associated with a DNA damage response, not replication, in human pancreatic β-cells

Lee, S., Hao, E., Levine, F., & Itkin‐Ansari, P. (2011) · Islets · doi:10.4161/isl.3.6.17923 · Cited by 24

Generation of highly potent DYRK1A-dependent inducers of human β-Cell replication via Multi-Dimensional compound optimization

Allegretti, P. A., Horton, T. M., Abdolazimi, Y., Moeller, H. P., Yeh, B. T., Caffet, M., Michel, G., Smith, M. A., & Annes, J. P. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.115193 · Cited by 24

Relationship between the level of fasting plasma glucose and beta cell functions in Chinese with or without diabetes

Pang, Bao, Yu-qian, Wang, Chen, LU, L., Jun-xi, Jia, J., Weiping, Xiang, ■., et al. (2008) · 中华医学杂志：英文版

ヒト膵β細胞量調節機構に関する包括的検討

税所, 芳., 山田, 健., 佐藤, 誠., 稲石, 淳., 村上, 理., & 北郷, 実. (2017) · Institutional Repositories DataBase (IRDB)

Pancreas fat and β cell mass in humans with and without diabetes : an analysis in the Japanese population(要旨)

ムラカミ, リ., MURAKAMI, R., & 村上, 理. (2017) · KeiO Associated Repository of Academic Resources (Keio University)

Pancreas fat and β cell mass in humans with and without diabetes : an analysis in the Japanese population(要約)

ムラカミ, リ., MURAKAMI, R., & 村上, 理. (2017) · KeiO Associated Repository of Academic Resources (Keio University)

Pancreas fat and β cell mass in humans with and without diabetes : an analysis in the Japanese population(審査報告)

ムラカミ, リ., MURAKAMI, R., & 村上, 理. (2017) · KeiO Associated Repository of Academic Resources (Keio University)